Oct 22, 2026 02:31AM
Oct 15, 2026 07:51AM
Aug 14, 2026 05:47AM
Aug 13, 2026 08:01AM
Aug 6, 2026 06:09AM
Jun 18, 2026 06:07AM
May 15, 2026 10:28AM Leerink Partners Starts Atrium Therapeutics (RNA) at Outperform
Apr 23, 2026 08:01AM
Mar 10, 2026 04:24PM
Feb 27, 2026 09:21AM
Feb 23, 2026 08:02AM
Jan 28, 2026 04:16PM
Jan 28, 2026 04:15PM
Nov 19, 2025 09:14AM Avidity announces managed access program for DMD therapy del-zota
Nov 12, 2025 06:39AM
Nov 10, 2025 05:44PM
Nov 7, 2025 04:09AM
Oct 29, 2025 02:27AM
Oct 28, 2025 04:32PM
Oct 28, 2025 03:26AM
Oct 28, 2025 03:24AM Chardan Capital Markets Downgrades Avidity Biosciences (RNA) to Neutral
Oct 27, 2025 10:38AM
Oct 27, 2025 10:38AM
Oct 27, 2025 07:30AM
Oct 27, 2025 07:05AM
Oct 27, 2025 06:20AM
Oct 27, 2025 03:56AM
Oct 27, 2025 02:55AM Bernstein SocGen Group Downgrades Avidity Biosciences (RNA) to Market Perform
Oct 27, 2025 12:28AM
Oct 26, 2025 11:32AM
Oct 13, 2025 09:01AM
Sep 17, 2025 12:57AM
Sep 15, 2025 07:28AM
Sep 12, 2025 05:03PM
Sep 12, 2025 10:41AM Avidity Biosciences (RNA) PT Raised to $65 at BofA Securities
Sep 11, 2025 08:18AM
Sep 10, 2025 10:07AM
Sep 10, 2025 10:06AM
Aug 30, 2025 04:00PM
Aug 6, 2025 11:23AM
Aug 6, 2025 11:20AM
Jul 10, 2025 06:23AM Goldman Sachs Resumes Avidity Biosciences (RNA) at Buy
Jun 27, 2025 07:09AM
Jun 24, 2025 09:40AM
Jun 17, 2025 05:54AM
Jun 10, 2025 06:40AM
Jun 9, 2025 12:51PM
Jun 9, 2025 07:01AM
May 13, 2025 06:59AM Avidity Biosciences (RNA) PT Lowered to $68 at H.C. Wainwright
May 8, 2025 08:10PM

483,152 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All